Effect | Increase |
Trial Design | Double blind |
Trial Length | 1-6 months |
Number of Subjects | 14 |
Sex | Both Genders |
Age Range | 45-64, 65+ |
Body Types | Overweight |
A reduction in triglycerides (27%) and vLDL were met with an increase in LDL-C (6%) and no significant influence on fasting HbA1c or glucose in type II diabetics given fish oil at 1,800mg EPA and 1,200mg DHA for 8 weeks. The activity of plasminogen inhibitor 1 increased 21%